I agree that this site is using cookies. You can find further informations here.
X
Arnott, I. D.
287  results:
Search for persons X
?
1

DOP17 Tofacitinib versus Vedolizumab Among Bio-naïve Patien..:

Gros, B ; Constantine-Cooke, N ; Kennedy, J...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i102-i103 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P860 Long-term outcomes and predictors of vedolizumab persi..:

Gros, B ; Ross, H ; Nwabueze, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1592-i1594 , 2024
Link: https://doi.org/10.1093/..
 
?
3

OP33 Results of a randomised controlled trial to evaluate I..:

Raine, T ; Vaja, S ; Subramanian, S...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i43-i46 , 2023
Link: https://doi.org/10.1093/..
 
?
4

P557 Analysis of colectomy rates and advanced therapy presc..:

Jenkinson, P ; Plevris, N ; Gros Alcalde, B...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i687-i689 , 2023
Link: https://doi.org/10.1093/..
 
?
5

P745 Multiple infliximab biosimilar switches appear to be s..:

Gros, B ; Plevris, N ; Constantine-Cooke, N...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i876-i876 , 2023
Link: https://doi.org/10.1093/..
 
?
6

P509 Surgery and biologic prescription rates for Crohn's di..:

Jenkinson, P ; Plevris, N ; Lyons, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i640-i640 , 2023
Link: https://doi.org/10.1093/..
 
?
7

P579 Rates, predictive factors and effectiveness of ustekin..:

Derikx, L ; Plevris, N ; Su, S...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i519-i520 , 2022
Link: https://doi.org/10.1093/..
 
?
8

P129 IBD care in the UK: A comprehensive, novel service ass..:

Wakeman, R ; Ainley, R ; Arnott, I D...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S220-S221 , 2021
Link: https://doi.org/10.1093/..
 
?
9

DOP72 Perianal Crohn's Disease in the biologic era: A popul..:

Jenkinson, P ; Plevris, N ; Lyons, M...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S105-S107 , 2021
Link: https://doi.org/10.1093/..
 
?
10

P330 Long-term outcomes following a switch from originator ..:

Derikx, L ; Dolby, H ; Plevris, N...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S353-S354 , 2021
Link: https://doi.org/10.1093/..
 
?
11

DOP11 Normalisation of faecal calprotectin within 12 months..:

Plevris, N ; Fulforth, J ; Jenkinson, P...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S048-S049 , 2020
Link: https://doi.org/10.1093/..
 
?
12

Temporal Trends in Surgical Resection Rates and Biologic Pr..:

Jenkinson, P W ; Plevris, N ; Siakavellas, S...
Journal of Crohn's and Colitis.  14 (2020)  9 - p. 1241-1247 , 2020
Link: https://doi.org/10.1093/..
 
?
13

P575 Real-world effectiveness and safety of ustekinumab for..:

PLEVRIS, N ; Robertson, A ; Fulforth, J...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S484-S484 , 2020
Link: https://doi.org/10.1093/..
 
?
14

Capsule endoscopy in suspected small bowel Crohn's disease ..:

Robertson, A.R. ; Yung, D.E. ; Arnott, I.D...
Digestive and Liver Disease.  51 (2019)  1 - p. 174-176 , 2019
Link: https://doi.org/10.1016/..
 
?
15

P459 Vedolizumab for the treatment of chronic pouchitis: th..:

Cesano, S ; Jones, G R ; Jenkinson, P W...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S341-S341 , 2019
Link: https://doi.org/10.1093/..
 
1-15